Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001213900-20-036343
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$7.97M | -$1.54M | -$4.51M | -$12.31M |
| EPS Diluted | -$1.26 | -$0.92 | -$0.25 | -$1.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
